Cargando…
Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations
Nanomedicines (NMs) have emerged as an efficient approach for developing novel treatment strategies against a variety of diseases. Over the past few decades, NM formulations have received great attention, and a large number of studies have been performed in this field. Despite this, only about 60 na...
Autores principales: | Tuguntaev, Ruslan G., Hussain, Abid, Fu, Chenxing, Chen, Haoting, Tao, Ying, Huang, Yan, Liu, Lu, Liang, Xing-Jie, Guo, Weisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118863/ https://www.ncbi.nlm.nih.gov/pubmed/35590412 http://dx.doi.org/10.1186/s12951-022-01451-4 |
Ejemplares similares
-
Osteopontin targeted theranostic nanoprobes for laser-induced synergistic regression of vulnerable atherosclerotic plaques
por: Xu, Mengqi, et al.
Publicado: (2022) -
Biomimetic nanomedicines for precise atherosclerosis theranostics
por: Tao, Ying, et al.
Publicado: (2023) -
Stimuli-responsive polymeric nanomaterials for rheumatoid arthritis therapy
por: Xie, Yingsi, et al.
Publicado: (2020) -
MSCs-engineered biomimetic PMAA nanomedicines for multiple bioimaging-guided and photothermal-enhanced radiotherapy of NSCLC
por: Yin, Yipengchen, et al.
Publicado: (2021) -
Nanomedicines for Near-Infrared Fluorescent Lifetime-Based Bioimaging
por: Lian, Xianhui, et al.
Publicado: (2019)